1,2-Dichloroethane → HCID 178521726, compound
Reaction equation
[O:1]1[CH2:6][CH2:5][N:4]([C:7]2[CH:31]=[CH:30][C:10]3[NH:11][C:12]([C:14]4[C:22]5[C:17](=[CH:18][CH:19]=[C:20]([NH2:23])[CH:21]=5)[N:16]([CH:24]5[CH2:29][CH2:28][CH2:27][CH2:26][O:25]5)[N:15]=4)=[N:13][C:9]=3[CH:8]=2)[CH2:3][CH2:2]1.N1(O)C2C=CC=CC=2N=N1.C(Cl)CCl.C(=O)(O)[O-].[Na+].[CH:51]1([C:54](O)=[O:55])[CH2:53][CH2:52]1>CN(C=O)C>[O:1]1[CH2:2][CH2:3][N:4]([C:7]2[CH:31]=[CH:30][C:10]3[NH:11][C:12]([C:14]4[C:22]5[C:17](=[CH:18][CH:19]=[C:20]([NH:23][C:54]([CH:51]6[CH2:53][CH2:52]6)=[O:55])[CH:21]=5)[N:16]([CH:24]5[CH2:29][CH2:28][CH2:27][CH2:26][O:25]5)[N:15]=4)=[N:13][C:9]=3[CH:8]=2)[CH2:5][CH2:6]1Participants
Procedure
3-(5-Morpholino-1H-benzo[d]imidazol-2-yl)-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-5-amine (30 mg, 0.072 mmol), 1H-benzo[d][1,2,3]triazol-1-ol (14.53 mg, 0.108 mmol), EDC (20.61 mg, 0.108 mmol) and sodium bicarbonate (6.02 mg, 0.072 mmol) was added to a solution of cyclopropanecarboxylic acid (6.17 mg, 0.072 mmol) in DMF (6 mL). The reaction mixture was stirred at room temperature for 24 h, and then the solvent was removed in vacuo. Purification by flash column chromatography (6% CH3OH/CH2Cl2) afforded the title compound (20 mg) as a solid. 1H NMR: (400 MHz, CD3OD): δ 8.47 (d, 1H, J=1.6 Hz), 7.75 (dd, 1H, J=2.0 and 9.2 Hz), 7.67 (d, 1H, J=8.8 Hz), 7.55 (d, 1H, J=8.4 Hz), 7.14 (m, 1H), 7.05 (dd, 1H, J=2.0 and 8.4 Hz), 5.86 (dd, 1H, J=2.4 and 9.6 Hz), 3.98 (m, 1H), 3.87 (m 4H), 3.81 (m, 1H), 3.16 (m, 4H), 2.64 (m, 1H), 2.14 (m, 2H), 1.81 (m, 2H), 1.71 (m, 2H), 0.99 (m, 2H), 0.88 (m, 2H); ESI-MS [M+H]+:487.22.
Workup
- customthe solvent was removed in vacuo
- customPurification by flash column chromatography (6% CH3OH/CH2Cl2)
Sources & evidence
- ORD record
- ord-68314b40ffb74a22a677d9f79660871e
- Source dataset
- uspto-grants-2013_10
- Patent number
- US08569511B2
Reaction notes
Loading…